Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Clinical applications of circulating tumor DNA in Hodgkin lymphoma60
CAR T-cell therapy comes of age: Introductory editorial for the special issue55
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial52
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?45
How to set up a clinical research center in Brazil, as an example of a middle-income country43
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation43
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies43
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1940
Epidemiology and etiology of diffuse large B-cell lymphoma36
Somatic mutations in “benign” blood diseases34
TET2 mutation as prototypic clonal hematopoiesis lesion34
Lessons learned from the Eµ-TCL1 mouse model of CLL32
The role of viruses in HIV-associated lymphomas27
Antibody and immunotherapy in diffuse large B-cell lymphoma26
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence25
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services24
Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?22
Vaccinations in patients with chronic lymphocytic leukemia21
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future18
1.4229159355164